Published in Yale J Biol Med on February 25, 1991
Mental illness in elementary-school-aged children. West J Med (1999) 0.84
Differences in younger, middle, and older children admitted to child psychiatric inpatient services. Child Psychiatry Hum Dev (2002) 0.80
Neurobiology of attention deficit disorder with hyperactivity: where have we come in 50 years? J Am Acad Child Adolesc Psychiatry (1987) 1.05
Language disorders in children referred for psychiatric services. J Am Acad Child Psychiatry (1983) 1.04
Suicidal behavior in child psychiatric inpatients and outpatients and in nonpatients. Am J Psychiatry (1986) 1.00
Schools are our community mental health centers. Am J Psychiatry (1968) 0.99
Clinical features of the borderline personality disorder. Am J Psychiatry (1980) 0.98
Ownership and mental-health services. A reappraisal of the shift toward privately owned facilities. N Engl J Med (1984) 0.96
Childhood comorbidity of anxiety/affective disorders and behavior disorders. J Am Acad Child Adolesc Psychiatry (1989) 0.90
Prevalence of unsuspected language disorders in a child psychiatric population. J Am Acad Child Adolesc Psychiatry (1989) 0.90
Hospitalization of adolescents for psychiatric and substance abuse treatment. Legal and ethical issues. J Adolesc Health Care (1989) 0.89
The neurobiology of obsessive-compulsive disorder. JAMA (1988) 0.89
Use of demographic and clinical characteristics in predicting length of psychiatric hospital stay: a final evaluation. J Consult Clin Psychol (1983) 0.86
Goal-directed treatment planning and the principles of brief hospitalization. J Am Acad Child Adolesc Psychiatry (1989) 0.83
Characteristics of children admitted to inpatient community mental health center. Arch Gen Psychiatry (1983) 0.83
Care of children with psychiatric disorders at community hospitals. Hosp Community Psychiatry (1988) 0.82
Child psychiatric disorders: prevalence and perspectives. Psychiatr Clin North Am (1985) 0.82
Changes in inpatient child psychiatry: consequences and recommendations. J Am Acad Child Adolesc Psychiatry (1988) 0.81
The development of an acute short-term inpatient child psychiatric setting: a pediatric-psychiatric model. Am J Psychiatry (1979) 0.80
Childhood disorder DRG: consideration for a predictive model. J Am Acad Child Adolesc Psychiatry (1989) 0.80
Short-term psychiatric hospitalization of children. Hosp Community Psychiatry (1987) 0.80
The DSM-III classification of the psychiatric disorders of infancy, childhood, and adolescence. J Am Acad Child Psychiatry (1980) 0.78
Issues in the classification of child and adolescent psychopathology. J Am Acad Child Adolesc Psychiatry (1988) 0.78
DRG prepayment: its purpose and performance. Bull N Y Acad Med (1989) 0.78
Integration of general hospital psychiatric services with freestanding psychiatric hospitals. Hosp Community Psychiatry (1989) 0.77
Comorbidity of other psychiatric disturbances in depressed, psychiatrically hospitalized children. Am J Psychiatry (1988) 0.77
The children's psychiatric hospital unit in the community: I. Concept and development. Am J Psychiatry (1978) 0.77
Residential treatment centers: peer review by APA and CHAMPUS. Hosp Community Psychiatry (1984) 0.77
Time-limited psychiatric hospitalization of children: a model and three-year outcome. Hosp Community Psychiatry (1987) 0.77
Developmental issues in the psychiatric hospitalization of children. Am J Psychiatry (1978) 0.77
Research on a children's psychiatric inpatient service. J Am Acad Child Adolesc Psychiatry (1989) 0.77
Toward diagnostic related groups in child psychiatry: a preliminary study. J Am Acad Child Psychiatry (1985) 0.77
Treatment planning in child psychiatry. J Am Acad Child Psychiatry (1984) 0.77
Mental hospitalization of troublesome youth: an analysis of skyrocketing admission rates. Stanford Law Rev (1988) 0.77
Resolved: child and adolescent psychiatric practice in the twenty-first century will largely be hospital based. J Am Acad Child Adolesc Psychiatry (1988) 0.76
Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity. J Am Acad Child Adolesc Psychiatry (1997) 7.10
The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry (1989) 6.98
Emergence of self-destructive phenomena in children and adolescents during fluoxetine treatment. J Am Acad Child Adolesc Psychiatry (1991) 3.02
Racial disparity in psychotropic medications prescribed for youths with Medicaid insurance in Maryland. J Am Acad Child Adolesc Psychiatry (1998) 2.30
The relationship of obsessive-compulsive disorder to possible spectrum disorders: results from a family study. Biol Psychiatry (2000) 2.29
Reduced basal ganglia volumes in Tourette's syndrome using three-dimensional reconstruction techniques from magnetic resonance images. Neurology (1993) 1.68
Hoarding in obsessive compulsive disorder: results from a case-control study. Behav Res Ther (2002) 1.63
Genome-wide association study of obsessive-compulsive disorder. Mol Psychiatry (2012) 1.57
The relationship between obsessive-compulsive disorder and anxiety and affective disorders: results from the Johns Hopkins OCD Family Study. Psychol Med (2001) 1.48
Childhood trichotillomania: clinical phenomenology, comorbidity, and family genetics. J Am Acad Child Adolesc Psychiatry (1995) 1.40
Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. Background and rationale for an initial controlled study of risperidone. Child Adolesc Psychiatr Clin N Am (2000) 1.29
Is obsessive-compulsive disorder an anxiety disorder, and what, if any, are spectrum conditions? A family study perspective. Psychol Med (2011) 1.25
Family study and segregation analysis of Tourette syndrome: evidence for a mixed model of inheritance. Am J Hum Genet (1996) 1.24
Genomewide linkage scan for obsessive-compulsive disorder: evidence for susceptibility loci on chromosomes 3q, 7p, 1q, 15q, and 6q. Mol Psychiatry (2006) 1.24
Elevated cerebrospinal fluid levels of oxytocin in obsessive-compulsive disorder. Comparison with Tourette's syndrome and healthy controls. Arch Gen Psychiatry (1994) 1.14
Personality disorders and normal personality dimensions in obsessive-compulsive disorder. Br J Psychiatry (2000) 1.12
Beyond the serotonin hypothesis: a role for dopamine in some forms of obsessive compulsive disorder? J Clin Psychiatry (1990) 1.08
The familial phenotype of obsessive-compulsive disorder in relation to tic disorders: the Hopkins OCD family study. Biol Psychiatry (2001) 1.07
Methylphenidate patterns among Medicaid youths. Psychopharmacol Bull (1997) 1.06
Cerebrospinal fluid biogenic amines in obsessive compulsive disorder, Tourette's syndrome, and healthy controls. Neuropsychopharmacology (1995) 1.05
Clonidine treatment of Gilles de la Tourette's syndrome. Arch Gen Psychiatry (1991) 1.04
A family-based association study of the glutamate transporter gene SLC1A1 in obsessive-compulsive disorder in 378 families. Am J Med Genet B Neuropsychiatr Genet (2009) 1.03
The role of central oxytocin in obsessive compulsive disorder and related normal behavior. Psychoneuroendocrinology (1994) 0.98
Obsessive-compulsive disorder: subclassification based on co-morbidity. Psychol Med (2008) 0.97
Critical review of tricyclic antidepressant use in children and adolescents. J Am Acad Child Adolesc Psychiatry (1999) 0.96
Tourette's syndrome: when habit-forming systems form habits of their own? Neuron (2000) 0.96
Human basal ganglia volume asymmetries on magnetic resonance images. Magn Reson Imaging (1993) 0.95
Prevalence variations in psychotropic treatment of children. J Child Adolesc Psychopharmacol (1998) 0.95
Meta-analysis of association between obsessive-compulsive disorder and the 3' region of neuronal glutamate transporter gene SLC1A1. Am J Med Genet B Neuropsychiatr Genet (2013) 0.93
Corpus callosum morphology from magnetic resonance images in Tourette's syndrome. Psychiatry Res (1994) 0.92
Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette's syndrome: preliminary clinical experience. J Am Acad Child Adolesc Psychiatry (1995) 0.92
Association of SLC6A4 variants with obsessive-compulsive disorder in a large multicenter US family study. Mol Psychiatry (2009) 0.92
Pharmacological treatment of childhood obsessive-compulsive disorder: from theory to practice. J Clin Child Psychol (2001) 0.91
Rebound phenomena in Tourette's syndrome after abrupt withdrawal of clonidine. Behavioral, cardiovascular, and neurochemical effects. Arch Gen Psychiatry (1986) 0.91
Childhood comorbidity of anxiety/affective disorders and behavior disorders. J Am Acad Child Adolesc Psychiatry (1989) 0.90
Selective serotonin reuptake inhibitors for children and adolescents. Curr Psychiatry Rep (2000) 0.88
The treatment of anxiety disorders in children and adolescents. Biol Psychiatry (1999) 0.88
Tourette's syndrome: clinical and neurochemical correlates. J Am Acad Child Adolesc Psychiatry (1988) 0.86
Fluvoxamine open-label treatment of adolescent inpatients with obsessive-compulsive disorder or depression. J Am Acad Child Adolesc Psychiatry (1994) 0.84
The relationship of pathologic skin picking to obsessive-compulsive disorder. J Nerv Ment Dis (2001) 0.84
Fluoxetine has no marked effect on tic symptoms in patients with Tourette's syndrome: a double-blind placebo-controlled study. J Child Adolesc Psychopharmacol (1997) 0.83
Psychostimulants in preschool children with attention-deficit/hyperactivity disorder: clinical evidence from a developmental disorders institution. J Am Acad Child Adolesc Psychiatry (2001) 0.81
Homeobox genes in obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet (2011) 0.81
Abnormal magnetic resonance imaging T2 relaxation time asymmetries in Tourette's syndrome. Psychiatry Res (1994) 0.81
Pharmacologic treatment of anxiety disorders in children and adolescents. Child Adolesc Psychiatr Clin N Am (2000) 0.80
Cerebrospinal fluid monoamine precursor and metabolite levels in children treated for leukemia: age and sex effects and individual variability. Biol Psychiatry (1986) 0.80
Brain monoamines and amino acids in Gilles de la Tourette's syndrome: a preliminary study of subcortical regions. Arch Gen Psychiatry (1992) 0.80
Tardive dyskinesia following haloperidol treatment in Tourette's syndrome. Arch Gen Psychiatry (1987) 0.80
Fluoxetine overdose in an adolescent. J Am Acad Child Adolesc Psychiatry (1989) 0.80
Elevated CSF dynorphin A [1-8] in Tourette's syndrome. Life Sci (1988) 0.80
Postmortem analysis of subcortical monoamines and amino acids in Tourette syndrome. Adv Neurol (1992) 0.79
Pediatric psychopharmacology: problems and prospects. J Child Adolesc Psychopharmacol (1998) 0.79
Rare plus common SERT variants in obsessive-compulsive disorder. Mol Psychiatry (2007) 0.79
Disruptive behavior, hyperactivity, and learning disabilities in children with Tourette's syndrome. Adv Neurol (1995) 0.79
Comparative physiological disposition of melatonin and its benzo(b)thiophene analog in the rat. Life Sci (1974) 0.78
MAOI treatment response: multiaxial assessment. J Affect Disord (1988) 0.78
Pharmacotherapy in children and adolescents with obsessive-compulsive disorder. Child Adolesc Psychiatr Clin N Am (1999) 0.78
Serotonin in human lumbar cerebrospinal fluid: a reassessment. Life Sci (1990) 0.77
Commentary: unmasked and uncontrolled medication trials in child and adolescent psychiatry. J Am Acad Child Adolesc Psychiatry (1998) 0.77
Pharmacotherapy of Tourette's syndrome and associated disorders. Psychiatr Clin North Am (1992) 0.77
Research on a children's psychiatric inpatient service. J Am Acad Child Adolesc Psychiatry (1989) 0.77
Pathogenesis of Tourette syndrome. Clues from the clinical phenotype and natural history. Adv Neurol (1992) 0.76
Low CSF 5HIAA and obsessions of violence: report of two cases. Psychiatry Res (1990) 0.76
Desipramine treatment of boys with attention-deficit hyperactivity disorder and tics: preliminary clinical experience. J Am Acad Child Adolesc Psychiatry (1988) 0.75
Neuroendocrine and behavioral effects of naloxone in Tourette syndrome. Adv Neurol (1992) 0.75
Psychosis in children: diagnosis and treatment. Dialogues Clin Neurosci (2001) 0.75
The ontogeny of 3,4-dihydroxyphenylacetic acid in human cerebrospinal fluid. J Neurol Neurosurg Psychiatry (1988) 0.75
Brief debrisoquin administration to assess central dopaminergic function in children. Life Sci (1986) 0.75
The role of advanced technology in inpatient child psychiatry: leading edge or useful aid? J Am Acad Child Adolesc Psychiatry (1990) 0.75
Cerebrospinal fluid dynorphin A[1-8] and beta-endorphin levels in Tourette's syndrome are unaltered. Biol Psychiatry (1999) 0.75
Assessment of dopaminergic function in children and adults: long and brief debrisoquin administration combined with plasma homovanillic acid. Psychopharmacol Bull (1987) 0.75
Fluoxetine treatment of obsessions and compulsions in patients with Tourette's syndrome. Am J Psychiatry (1988) 0.75
Psychopharmacology of obsessive-compulsive disorder in Tourette syndrome. Adv Neurol (1992) 0.75
Plasma-free homovanillic acid: within- and across-day stability in children and adults with Tourette's syndrome. Life Sci (1987) 0.75
The new antidepressants. Selective serotonin reuptake inhibitors. Pediatr Clin North Am (1998) 0.75
Assessment of central dopaminergic function using plasma-free homovanillic acid after debrisoquin administration. J Neural Transm (1986) 0.75
Neuroleptic malignant syndrome in children and adolescents: time to stop, look, and listen. J Child Adolesc Psychopharmacol (1992) 0.75